Security key
59935V107
Milestone Pharmaceuticals Inc. - Common Shares, no par value (MIST)
CUSIP: 59935V107
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 24,552,580
- Total 13F value
- $57,943,143
- Share change
- -4,435,736
- Put/Call ratio
- 63%
- SEC-reported price per share
- $2.36
- Number of holders
- 46
- Value change
- -$9,780,800
- Number of buys
- 22
- Number of sells
- 20
- Shares outstanding
- 124,217,096
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
46
Top holders
10
MIST full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Milestone Pharmaceuticals Inc. SEC filings
Milestone Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59935V107
Recent filing periods:
Ownership snapshot
Top reported holders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
3/4/5
Lead comparable stake: 4%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
4%
RTW INVESTMENTS, LP
2.6%
MILLENNIUM MANAGEMENT LLC
2.2%
Alta Fundamental Advisers LLC
2.1%
CITADEL ADVISORS LLC
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
Company
|
4%
|
$7,556,443
4,971,344 shares
|
— | 30 Sep 2024 |
| RTW INVESTMENTS, LP |
3/4/5
13F
10%+ Owner · Company
|
2.6%
from 13F
|
$28,360,648
3,256,102 shares
|
— | 22 Mar 2023 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
2.2%
|
$4,223,358
2,778,525 shares
|
— | 30 Sep 2024 |
| Alta Fundamental Advisers LLC |
13F
Company
|
2.1%
|
$4,041,055
2,658,589 shares
|
— | 30 Sep 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.7%
|
$3,133,514
2,061,522 shares
|
— | 30 Sep 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.6%
|
$3,040,000
2,000,000 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
46
Shares
24,552,580
Rows available
46
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
41
Q4 2024 holders
46
Holder diff
5
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend